Watch Ticker

Cellectis S.A. American Depositary Shares

Go to Cellectis S.A. American Depositary Shares Website

$2.72

0.19 (7.51%)

Live

Previous Close

$2.53

Day Range

$2.56 - $2.74

Previous Day Range

$2.51 - $3.08

Market Cap

$253.8 million USD

Day Vol.

173209

Previous Day Vol.

340529

Currency

USD

Primary Exchange

Nasdaq

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the fi...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Cellectis présente sa stratégie « Smart CAR T » pour améliorer l’efficacité contre les tumeurs solides à l’AACR-IO 2025

Cellectis présente une stratégie innovante d'ingénierie des cellules T qui exploite les propriétés pro-inflammatoires de l'interleukine 2 (IL-2) dans l'objectif d'améliorer l'efficacité des cellules CAR T contre les tumeurs solides.

Related tickers: CLLS.

Read Full Article

N/A - Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025

Cellectis, a clinical-stage biotechnology company, presented data on its strategy to enhance CAR T cell efficacy against solid tumors by leveraging the pro-inflammatory properties of interleukin 2 (IL-2) using its TALEN gene editing technology.

Related tickers: CLLS.

Read Full Article

Trending Tickers

Please sign in to view